|
Health-related quality of life (HRQoL) among pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibroma (PN) in the United States (U.S.). |
|
|
Employment - Merck Sharp & Dohme |
Stock and Other Ownership Interests - Merck Sharp & Dohme |
|
|
Employment - AstraZeneca; Syneos Health (I) |
Stock and Other Ownership Interests - AstraZeneca |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
Research Funding - Merck Sharp & Dohme (Inst) |
|
|
Research Funding - Merck Sharp & Dohme (Inst) |
|
|
Research Funding - Merck Sharp & Dohme (Inst) |
|
|
Research Funding - Merck Sharp & Dohme (Inst) |
|
|
No Relationships to Disclose |